Gara Jalqabaatti › Kansarii Prostate › Washington › Seattle
Qorannoo klinikaalii Kansarii Prostate Seattle, WA keessatti
Qorannoo 42 Kansarii Prostate f Seattle fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- fi 1 dabalataa
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Swedish Medical Center, Seattle
Precision-Based Genomics in Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Washington, Seattle
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Research Center, Seattle
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Namoota walitti qabaa jiraSadarkaa 2/3
- Fred Hutchinson Cancer Research Center, Seattle
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center, Seattle
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Namoota walitti qabaa jiraSadarkaa 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Namoota walitti qabaa jiraSadarkaa 3
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Washington Medical Center, Seattle
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Washington, Seattle
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Investigational Site Number: 400, Seattle
Prostate Active Surveillance Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Namoota walitti qabaa jiraSadarkaa 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Washington Medical Center, Seattle
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutchinson Cancer Center, Seattle
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- fi 4 dabalataa
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutchinson Cancer Center, Seattle
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
Namoota walitti qabaa jira
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- fi 4 dabalataa
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Namoota walitti qabaa jiraSadarkaa 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- VA Puget Sound Health Care System, Seattle
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Center, Seattle
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Namoota walitti qabaa jiraSadarkaa 2
- Swedish Medical Center-Ballard Campus, Seattle
- FHCC South Lake Union, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- fi 4 dabalataa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Seattle
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- FHCC South Lake Union, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Washington, DCQorannoo 38
- Dallas, TXQorannoo 36
Qorannoo biroo Seattle keessatti
- Kansara Qara'a Non-Small CellQorannoo 53
- Saree (Gosoota Hunda)Qorannoo 49
- Leukemia Myeloidii HamaaQorannoo 40
- Saree OljooQorannoo 39
- Kansara MetastatikiiQorannoo 39
- Kansarii ColorectalQorannoo 34
- Dhibee QaraQorannoo 33
- Kansarii OvariiQorannoo 30
- Myeloma Baay’eeQorannoo 22
- Myelodysplastic SyndromesQorannoo 21
- Leukemia Lymphoblasticii HamaaQorannoo 21
- Dukkana BladderQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.